SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001683168-22-000270
Filing Date
2022-01-14
Accepted
2022-01-14 16:44:15
Documents
12
Period of Report
2022-01-14
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 FORM 8-K snoa_8k.htm   iXBRL 8-K 24624
  Complete submission text file 0001683168-22-000270.txt   196993

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE snoa-20220114.xsd EX-101.SCH 3045
3 XBRL LABEL FILE snoa-20220114_lab.xml EX-101.LAB 34476
4 XBRL PRESENTATION FILE snoa-20220114_pre.xml EX-101.PRE 22603
6 EXTRACTED XBRL INSTANCE DOCUMENT snoa_8k_htm.xml XML 3585
Mailing Address 645 MOLLY LANE, SUITE 150 WOODSTOCK GA 30189
Business Address 645 MOLLY LANE, SUITE 150 WOODSTOCK GA 30189 800-759-9305
Sonoma Pharmaceuticals, Inc. (Filer) CIK: 0001367083 (see all company filings)

IRS No.: 680423298 | State of Incorp.: DE | Fiscal Year End: 0331
Type: 8-K | Act: 34 | File No.: 001-33216 | Film No.: 22532342
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences